Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
Prostate Cancer and Prostatic Diseases|July 8, 2022
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapyMaarten J van der Doelen, Irma M Oving, Dirk N J Wyndaele, et al.
Prostate Cancer and Prostatic Diseases|July 13, 2021
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancerBastiaan M Privé, Peter H J Slootbeek, Babette I Laarhuis, et al.
Cancers|January 8, 2023
PSMA-RLT in Patients with Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective StudyAmina Banda, Bastiaan M Privé, Youssra Allach, et al.
Insect Molecular Biology|May 21, 2010
Comprehensive survey of developmental genes in the pea aphid, Acyrthosiphon pisum: frequent lineage-specific duplications and losses of developmental genesS Shigenobu, R D Bickel, J A Brisson, et al.
Nature Communications|October 18, 2022
Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinomaKatrin Rabold, Martijn Zoodsma, Inge Grondman, et al.
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP|November 14, 2002
The biotic ligand model: a historical overviewPaul R Paquin, Joseph W Gorsuch, Simon Apte, et al.
BMC Cancer|September 15, 2020
Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
The Lancet. Oncology|April 2, 2026
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 studyBastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
Trials|November 5, 2021
Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trialBastiaan M Privé, Marcel J R Janssen, Inge M van Oort, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2021
Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot StudyBastiaan M Privé, Steffie M B Peters, Constantijn H J Muselaers, et al.
Pageof 55